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Abstract Mutations in the OPA1 gene are associated with
autosomal dominant optic atrophy. OPA1 encodes a dynamin-
related protein orthologous to Msp1 of Schizosaccharomyces
pombe and Mgm1p of Saccharomyces cerevisiae, both involved
in mitochondrial morphology and genome maintenance. We
present immuno-£uorescence and biochemical evidences showing
that OPA1 resides in the mitochondria where it is imported
through its highly basic amino-terminal extension. Proteolysis
experiments indicate that OPA1 is present in the inter-mem-
brane space and electron microscopy further localizes it close
to the cristae. The strong association of OPA1 with membranes
suggests its anchoring to the inner membrane. # 2002 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Conventional dynamins are large GTPases involved in ve-
sicular tra⁄c and endocytosis [1]. Di¡erent subfamilies of dy-
namin-like proteins share a highly conserved GTPase domain
and take part in a variety of cellular processes including anti-
viral activity, plant cell plate formation and chloroplast bio-
genesis or mitochondrial morphology [1].
Two subfamilies of dynamin-like proteins have recently
been linked to mitochondrial morphology and distribution.
One comprises Dnm1p in Saccharomyces cerevisiae and its
orthologues Drp1 in Caenorhabditis elegans and DLP1/
DRP1 in mammals. These proteins punctuate constriction
sites of the mitochondrial network where they promote ¢ssion
of the outer membrane (OM) [2^5]. The morphology of this
membrane is regulated by ¢ssion forces driven by Dnm1p and
antagonistic fusion events controlled by Fzo1p or mitofusin, a
large GTPase unrelated to dynamins [6^10]. A second sub-
family of mitochondrial dynamin-like proteins includes
Mgm1p in S. cerevisiae [11^14] and Msp1 in Schizosaccharo-
myces pombe [15,16] which were shown to be involved in the
maintenance of the mitochondrial genome and network, pos-
sibly by modulating inner membrane (IM) dynamics.
We have recently identi¢ed OPA1 [17,18], the human or-
thologue of Msp1/Mgm1p, and found that mutations in the
OPA1 gene were associated with the most frequent form of
autosomal dominant optic atrophy (ADOA, MIM165500),
which features a progressive loss of retinal ganglion cells
that often lead to legal blindness [19,20]. By analogy with
Msp1/Mgm1p functions and since the mitochondrial network
of monocytes from ADOA patients appears abnormally con-
densed [17], this may represent the ¢rst case of a mitochon-
drial disease caused by alteration of the mitochondrial net-
work. A controversy persists on the localization of these
proteins. Msp1 has been reported to be anchored to the ma-
trix side of the IM [16], whereas Mgm1p has been shown to be
anchored to the cytoplasmic face of the OM [13], or periph-
eral to the IM exposed to the inter-membrane space (IMS)
[14]. To gain insights into the pathophysiology of ADOA, we
address here the issue of OPA1 localization.
2. Materials and methods
2.1. Recombinant DNA technologies
For expression as green £uorescent protein (GFP) fusion proteins,
OPA1 fragments corresponding to full length protein (1^960) or to
deleted forms (1^123 and 125^960), were cloned into pEGFP-N3
(Clontech) yielding OPA1-GFP, mtsOPA1-GFP and vmtsOPA1-
GFP, respectively. For in vitro import, OPA1 (1^123) was fused at
the NH2-terminus of dihydrofolate reductase (DHFR) into pSP65
(Promega) yielding mtsOPA1-DHFR.
2.2. Antibodies
OPA1 (261^904) produced from the pET15-b (Novagen) Escheri-
chia coli expression vector was extracted from sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE) to immunize rabbits
(Eurogentec). Anti-OPA1 antibodies were a⁄nity-puri¢ed from crude
serum by incubation on strips of nitrocellulose containing the OPA1
(261^904). Antisera to human Tim13 and to rat UCP1 were provided
respectively by C. Koehler (UCLA, Los Angeles, CA, USA) and L.
Casteilla (UMR5018, Toulouse, France). Commercial antibodies were
from the sources indicated: anti-HSP60 (LK2, Sigma), anti-FGF
(SC79, Santa Cruz Biotechnology), anti-cytochrome c (7H8.2C12,
Zymed Laboratories), anti-Bcl-2 (clone 124, Roche Diagnostics),
anti-cytochrome b and Alexa-594 anti-rabbit IgG and Alexa-488
anti-mouse IgG (Molecular Probes), anti-rabbit IgG-HRP and anti-
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mouse IgG-HRP (New England Biolabs) and gold-conjugated goat
anti-rabbit IgG (British BioCell).
2.3. Culture, transfection and £uorescence microscopy
HeLa and NIH-3T3 cells were cultured in Dulbecco’s modi¢ed
Eagle’s medium (DMEM), 10% fetal calf serum (FCS), and trans-
fected with ExGen-500 (Euromedex). For £uorescence microscopy,
cells were ¢xed (30 min, 4‡C) in phosphate-bu¡ered saline (PBS),
3.7% paraformaldehyde and permeabilized in 100% methanol
(10 min, 320‡C) and in PBS, 0.25% Triton X-100 (5 min, room
temperature). Immunolabeling was in PBS, 1% bovine serum albumin
(BSA), using antibodies as indicated in the ¢gure legends, and Alexa-
594 anti-rabbit IgG and Alexa-488 anti-mouse IgG (1/500).
2.4. Cell fractionation
Cells were suspended in mitochondrial bu¡er (MB, 210 mM man-
nitol, 70 mM sucrose, 1 mM EDTA and 10 mM HEPES pH 7.5)
supplemented with a cocktail of protease inhibitors (Boehringer)
and broken by 15^20 strokes of a tight-¢tting Dounce homogenizer.
The suspension was centrifuged (800Ug, 4‡C, 10 min) and the super-
natant spun (15 000Ug, 4‡C, 15 min) to separate the mitochondrial
pellet from the cytosol plus light membrane fraction.
Tissues were collected, minced and trimmed for contaminating tis-
sues in ice-cold MB. They were blended at maximal speed in a glass-
Te£on Potter^Elvenjehm homogenizer. The homogenates were decan-
ted for 5 min and mitochondrial fractions were obtained as above.
To assess membrane association, mitochondria in hypo-osmotic
bu¡er (MB with 1/10 concentrations of mannitol and sucrose) were
fragilized by three freeze-thaw cycles and sonicated three times for 15 s
on ice. Residual mitochondria were removed (12 000Ug, 4‡C, 10 min)
and the supernatant made either 1 M NaCl or 0.1 M Na2CO3, pH 11
and incubated for 30 min on ice with frequent vortexing. The solution
was centrifuged (150 000Ug, 4‡C, 45 min) to separate the supernatant
from the membrane pellet.
To determine the sub-compartmentalization, mitochondria were
suspended in MB containing proteinase K and the indicated concen-
trations of digitonin or Triton X-100. After 30 min on ice, proteolysis
was terminated by adding 5 mM PMSF and Laemli’s sample bu¡er,
and heating at 90‡C for 10 min.
Samples (100^200 Wg of mitochondrial proteins) were analyzed by
SDS^PAGE and Western blotting using the antibodies indicated and
anti-rabbit IgG-HRP or anti-mouse IgG-HRP (1/5000).
2.5. In vitro import of OPA1 into isolated mitochondria
The mtsOPA1-DHFR and mtsATP synthase su9-DHFR (gift from
G. Schatz, Basel, Switzerland, [21]) were translated in vitro (TNT0
SP6 Quick Coupled Transcription/Translation kit, Promega) in the
presence of [35S]methionine (Amersham). Import of the translated
products into isolated mitochondria (400 Wg of protein), inhibition
by valinomycin (1 Wg/ml) and sensitivity of the imported peptides to
trypsin digestion (1 mg/ml) were performed as described elsewhere
[16].
2.6. Immuno-electron microscopy
Rat brown adipose tissue was ¢xed for 2 h with 4% paraformalde-
hyde in PBS, pH 7.2, incubated in 1% NH4Cl for 1 h and dehydrated
in increasing concentrations of ethanol. Ethanol was progressively
exchanged with LRWhite (Euromedex) and polymerization lasted
for 2 days at 46‡C. Thin sections adsorbed on to nickel grids were
labeled in PBS, 0.2% Tween-20, 2% BSA using a⁄nity-puri¢ed anti-
OPA1 antibodies (1/5), or anti-UCP1 serum (1/20), and 10 nm gold
particles conjugated to anti-rabbit IgG antibodies (1/100). Sections
were stained with 1% uranyl acetate and 0.3% lead citrate, and imaged
in a JEOL-1200 EX electron microscope at 80 kV.
3. Results
3.1. OPA1 is localized in the mitochondrial network
The cellular localization of OPA1 was studied by raising
antibodies against recombinant OPA1 which were used to
characterize fractions of HeLa cells by Western blots (Fig.
1A). Cell fractionation was controlled using antibodies against
the cytosolic ¢broblast growth factor and the mitochondrial
cytochrome b. OPA1 was present in equal amounts in the
total and mitochondrial fractions but absent from the fraction
containing the cytosol plus light membranes. The estimated
molecular weight of OPA1 (86 kDa) was somewhat lower
than the 102 kDa predicted for the mature OPA1 product
(see below). Similar results (not shown) were obtained using
Fig. 1. OPA1 is localized in the mitochondria. A: Identical cell-
equivalent amounts of HeLa cells post-nuclear supernatant (Tot,
400 Wg of protein) separated into cytosol plus light membranes
(Cyt) and mitochondrial (Mit) fractions, and mitochondria (100 Wg
of protein) from human lymphocytes (Ly) and rat liver (Liv), skele-
tal muscle (Mu), heart (He) and brain (Br) were analyzed by West-
ern blots using antibodies against OPA1 (1/300), mitochondrial cy-
tochrome b (Cyt b, 1/400) and cytosolic ¢broblast growth factor
(FGF, 1/1000). Positions of molecular weight markers (kDa) are
shown between the two panels. B: Fluorescence micrographs of
¢xed HeLa cells treated with antibodies against OPA1 (1/150), or
the corresponding pre-immune serum (PI, 1/150), or against mito-
chondrial cytochrome b (Cyt b, 1/150) or HSP60 (1/150).
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other cell lines (NIH-3T3 and MCF7) and/or another immune
serum against an OPA1 peptide (571^585). The 86 kDa form
also predominated in human lymphocytes, and in rat liver,
muscle and heart, but a 92 kDa form was almost equally
represented in brain (Fig. 1A).
In immuno-£uorescence experiments on HeLa cells (Fig.
1B), ¢lamentous elongated structures distributed throughout
the cytoplasm were similarly decorated by antibodies against
OPA1 or the mitochondrial protein HSP60 or cytochrome b,
showing colocalization of these proteins. No speci¢c £uores-
cence was observed using the pre-immune serum.
3.2. The basic-rich N-terminal part of OPA1 is a bona ¢de
mitochondrial targeting signal (mts)
The highly basic amino-terminus of OPA1 presumably con-
stitutes an mts. This was checked by studying the cellular
distribution of GFP chimeric proteins comprising various
OPA1 fragments, after transient expression in NIH-3T3 cells
(Fig. 2A). Whereas £uorescence associated with pEGFP was
concentrated in the nucleus and fainter in the cytoplasm,
OPA1-GFP labeled a network of cytoplasmic tubules super-
imposed to that visualized using antibodies to HSP60. The
basic-rich 120 amino-terminal residues of OPA1 were su⁄-
cient to address mtsOPA1-GFP to the mitochondrial network
which appeared in this case as dots (the di¡erent morphology
of the mitochondrial network between these two situations is
addressed in Section 4). In contrast, the OPA1vmts-GFP chi-
mera, which lacked this amino-terminal extension, displayed
di¡use cytoplasmic £uorescence.
The mts property of the OPA1 NH2-terminal region was
further established by fusing it with DHFR, a cytoplasmic
enzyme, and assaying the localization of the chimera upon
import into isolated mitochondria (Fig. 2B, top). The in vitro
translated precursor of mtsOPA1-DHFR (p1) was associated
with mitochondria, and yielded two maturation products (m1
and m1P) only when the membrane potential was not dis-
rupted by valinomycin. OPA1 was addressed inside mitochon-
dria since the imported peptides were resistant to trypsin
digestion. This assay was validated using the mts of IM
ATP synthase subunit 9 fused to DHFR. In the presence of
an intact membrane potential, the precursor (p2) yielded a
maturation product (m2) which was also resistant to proteol-
ysis. In the amino-terminal part of OPA1 (Fig. 2B, bottom),
the cleavage region predicted from the apparent molecular
weights of the maturation peptides indeed displayed a canon-
ical sequence for a two-step cleavage site by matrix processing
peptidases [22].
3.3. OPA1 resides in the IMS tightly attached to the membrane
The submitochondrial localization of endogenous OPA1
was analyzed by electron microscopy using antibodies to
OPA1 and rat brown adipocytes that showed large mitochon-
dria with well-de¢ned and highly structured cristae. Most gold
grains were found within the mitochondria (89U 5%, n=736),
close to the cristae and no labeling occurred on the external
border delimited by the OM. Labeling of the cristae by anti-
OPA1 was con¢rmed by the similar pattern of gold grain
distribution obtained using antibodies to UCP1 (Fig. 3A), a
cristae marker [23].
Proteolysis experiments on intact mitochondria or after
progressive solubilization of the OM by digitonin (Fig. 3B),
indicated that OPA1 was digested together with the IMS
marker Tim13 whereas Bcl-2, an OM protein facing the cyto-
sol, was readily digested on intact mitochondria, and cyto-
chrome b, a matricial IM marker, required solubilization of
the IM by Triton X-100. A similar result was obtained by
Fig. 2. The basic-rich 120 amino-terminal residues of OPA1 consti-
tute a bona ¢de mts. A: NIH-3T3 cells transiently expressing the
plasmids indicated on the left side were visualized by direct GFP
£uorescence (left panels) and by staining with anti-HSP60 (1/150)
(right panels). B: In vitro translation products (IVT) of plasmids
mtsOPA1-DHFR and mtsATP synthase su9-DHFR were imported
into mitochondria in the absence (3) or presence (+) of valinomycin
(Val) and washed mitochondria were digested (+) or not (3) with
trypsin (Tryp). The NH2-terminal sequence of OPA1 is displayed at
the bottom, showing the consensus motif RXxXXS/T (x is any of
the hydrophobic residues F, L, V or I) for two-step cleavage sites
(triangles) of mitochondrial precursors and the putative transmem-
brane domain (underlined). The migration and estimated molecular
weights of the OPA1-DHFR precursor (p1) and intermediate (m1P)
and mature (m1) import products are indicated.
FEBS 26275 8-7-02
A. Olichon et al./FEBS Letters 523 (2002) 171^176 173
osmotic swelling of mitochondria: OPA1 was digested to the
same extent as Tim13 (respectively 78 and 76%), while most of
the matrix protein Hsp60 (78%) was protected (data not
shown).
The association of OPA1 to membranes was studied on
isolated mitochondria after incubation with either 1 M
NaCl or 0.1 M Na2CO3, pH 11 (Fig. 3C). Whatever the treat-
ment used, OPA1 remained in the membrane pellets as did the
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integral membrane protein Bcl-2 [24], whereas cytochrome c,
peripherally associated to the IM [25], was readily extracted
by either treatment.
4. Discussion
OPA1 is the ¢rst dynamin-related protein so far identi¢ed
as responsible for a human disease. As an approach to its
function and given the controversy on the presence of orthol-
ogous yeast proteins in the di¡erent mitochondrial compart-
ments, it was of interest to clarify its submitochondrial local-
ization. We have shown here by cellular fractionation and
immuno-£uorescence studies that OPA1 is localized in the
mitochondrial network. As expected from the distribution of
its mRNA [17,18], OPA1 was present in each mammalian
tissue and cell line examined. The mitochondrial nature of
OPA1 correlated with structural features of its N-terminal
region [26,27], which was shown to contain a bona ¢de mts
within the ¢rst 120 residues. Electron microscopy further lo-
calized OPA1 within the mitochondria with no labeling on the
periphery, exactly as observed for the IM-associated cristae
marker UCP1 [23]. This suggested that OPA1 is associated to
cristae, facing either the matrix or the IMS volume contained
within cristae cisternae [28]. Since OPA1 is accessible to pro-
tease, as is the IMS marker Tim13, and strongly associated
with membranes, we propose that it is anchored to the IM
through its N-terminal transmembrane segment, the bulk of
the protein facing the intracristae IMS. This contrasts with
data from the literature suggesting that Mgm1p is cytoplas-
mic, anchored to the OM [13], and that Msp1 is attached to
the IM, facing the matrix [16]. In these reports however, pro-
tease access to IMS markers, either before [13] or after [16]
osmotic rupture of the OM, was not assessed. Nevertheless,
in a recent study [14], the Mgm1p localization indeed agrees
with that of OPA1, in the IM facing the IMS.
OPA1 was detected as multiple molecular weight forms
among which the 86 kDa one predominated. This molecular
weight is signi¢cantly lower than the 102 kDa anticipated
from the use of the two-step cleavage site proposed in the
NH2-terminus of the precursor. N-terminal maturation of
OPA1 to yield the 86 kDa form would have necessitated the
cleavage of about 220 amino acid residues, in a region devoid
of recognition sites for mitochondrial processing peptidases,
eliminating the apparently essential membrane anchor. C-ter-
minal maturation is also unlikely since deletion of few resi-
dues from this region has been associated with ADOA [29].
Nor can alternative splicing explain this seemingly low molec-
ular weight, since the smallest form identi¢ed would have a
predicted molecular weight of 98 kDa [29]. The apparent 86
kDa molecular weight of OPA1 may rather result from post-
translational modi¢cations and/or from an aberrant ‘confor-
mational’ migration.
Modi¢cations of the mitochondrial morphology were ob-
served in cells transfected by di¡erent OPA1 constructs. A
punctuate structure, as seen in untransfected cells, was ob-
tained with mtsOPA1-GFP while OPA1-GFP induced a ¢la-
mentous network. As for Mgm1p in S. cerevisiae [14], ectopic
expression of OPA1 may thus modify the fusion/¢ssion equi-
librium of the mitochondrial network. Given its likely local-
ization in the intracristae IMS, the dynamin-related OPA1
could modulate the cristae dynamics. It may for example par-
ticipate in cristae formation during increased respiration and/
or energy production. OPA1 may also play a major role in
mobilization of the highly sequestered content of cristae cis-
ternae [28], as may be the case during apoptosis-induced cy-
tochrome c release [30]. Extensive dysfunction of OPA1 on
IM dynamics would ultimately lead to the more drastic alter-
ation of the mitochondrial network as observed here.
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